Plus Three

Plus Three

Plus Three attempts to make sense of the complex connections between drugs, science, capitalism, policy, and culture. The podcast is co-hosted by Psymposia co-founder Brian Normand, psychedelics researcher Nese Devenot, evolutionary ecologist Brian Pace, and underground researcher David Nickles. Subscribe and listen today on Apple Podcasts, Google Play, Spotify, Stitcher, Radio Public, Deezer, RSS, or psymposia.com

Amidst Pandemic, Psychedelic Investor Christan Angermayer Can’t Imagine Life Beyond Capitalism

As the coronavirus pandemic rages on, Christian Angermayer, the world’s largest psychedelic pharmaceutical investor and founder of ATAI Life Sciences, calls to sacrifice public health for the sake of “the economy.”

“Flattening The Curve is Complete BS”: Pandemic Advice From Psychedelic Investor Christian Angermayer

In response to the coronavirus pandemic, Christian Angermayer—the world's largest psychedelic pharmaceutical investor and founder of ATAI Life Sciences—dismisses medical experts in his desperation to reboot the economy.

Dear Psychedelic Researchers

The coronavirus has made it clear that psychedelic medicalization will not revolutionize mental healthcare without systemic socioeconomic change.

Capitalism can’t save us from coronavirus. Neither can psychedelics.

In the midst of increasing global engagement with the fallout of the novel coronavirus, we examine some responses to the pandemic within the "psychedelic community.” Recognizing that the US has a longstanding history of privatizing profits while socializing costs, we also discuss the normalization of a "capitalist animism"—treating social phenomena like markets or financial capital as living entities—that fixates on "economic health" at the expense of public health. As this unprecedented situation continues to unfold, we explore some considerations for this sudden period of social isolation within a broader culture of social alienation.

+ Alan Piper – Strange Nazis

Alan Piper is a maverick historian of ideas with a penchant for unique, deep dives into rich veins of psychedelia. Piper’s 2015 monograph, Strange Drugs Make for Bedfellows: Ernst Jünger, Albert Hofmann, and the Politics of Psychedelics was foundational for the critique explored in Brian Pace’s controversial Lucy in the Sky with Nazis: Psychedelics and the Right Wing. In this interview, Pace interviews Piper about Hofmann tripping buddy and Wehrmacht Captain Jünger, LSD and ideology— clarifying concepts and dispelling myths.

This Is What Psychedelic Mainstreaming Looks Like

It's not the Hokey Pokey, but psychedelic mainstreaming seems to be what it's all about. We explore some of the realities and questions of what it means to take psychedelics "mainstream.”

A Statement Regarding “The Emergence of a New Market: Psychedelic Science Conferences”

Our statement on a recent Chacruna article by Dr. Bia Labate

Lucy In the Sky with Nazis

We discuss our recent article, Lucy in the Sky with Nazis: Psychedelics and the Right Wing, which stirred up quite a bit of controversy. So to stir things up a little more, we’ve unpacked some of our perspectives while exploring questions of psychedelics as non-specific amplifiers of consciousness, the far right, the so-called “Intellectual Dark Web,” white supremacy, and psychedelics and social change.

Manufacturing Authority

Well, it’s official, psychedelics have entered the corporate-wellness mainstream. If you have any doubts, check out Gwyneth Paltrow’s new Netflix series, The Goop Lab. Or maybe don’t.

Why We Do What We Do

The team shares their personal stories and talk about how and why they became involved in psychedelic advocacy and drug policy reform. Happy New Year y’alls.